CBE Pure Solutions Pty Ltd

Accelagen is a Melbourne-based Contract Research Organisation (CRO) specializing in biopharmaceutical and medical device development. Founded in 2010, the company provides comprehensive clinical research, regulatory affairs, and biometrics services supporting clients from preclinical stages through commercialization. With 51-200 employees, Accelagen offers clinical trial management, strategic regulatory consulting, biostatistics, data management, medical writing, pharmacokinetics, site identification, and product lifecycle management. The company employs a proprietary 'reverse journey mapping' approach to streamline regulatory pathways and market approval across Australia, North America, Asia-Pacific, and Europe. Accelagen has delivered 100+ clinical trials, 339 device approvals, and 57 IND/IDE submissions, maintaining expertise across multiple therapeutic areas including cell and gene therapy, ophthalmology, and other specialties.